Study ID: ABS-AS-306
Study Title
- A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing
Teva Identifier
- ABS-AS-306
ClinicalTrials.gov Identifier
- NCT01218009
Study Status
- Terminated
Trial Condition(s)
- Asthma
Interventions
- Drug: Placebo Spiromax | Drug: Albuterol Spiromax
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 12 Years and older
Trial Duration
- 10/01/2010 - 12/01/2010
Phase
- Phase 3
Study Type
Interventional